高级检索
当前位置: 首页 > 详情页

Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Sichuan Univ, West China Hosp, Clin Res Ctr Resp Dis, Dept Resp & Crit Care Med, Chengdu 610041, Sichuan, Peoples R China [2]Sichuan Univ, Frontiers Sci Ctr Dis Related Mol Network, Lab Pulm Immunol & Inflammat, Chengdu, Peoples R China [3]Sichuan Univ, West China Hosp, Dept Integrated Tradit Chinese & Western Med, Pneumol Grp, Chengdu, Peoples R China [4]Univ Newcastle, Natl Hlth & Med Res Council, Ctr Res Excellence Severe Asthma & Treatable Trai, Newcastle, NSW, Australia [5]John Hunter Hosp, Hunter Med Res Inst, Dept Resp & Sleep Med, Newcastle, NSW, Australia [6]Fudan Univ, Resp Div, Shanghai Inst Resp Dis, Zhongshan Hosp, Shanghai, Peoples R China [7]Kings Coll London, Fac Life Sci & Med, Ctr Human & Appl Physiol Sci, Sch Basic & Med Biosci, London, England [8]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Resp & Crit Care Med, Wuhan, Peoples R China [9]Guangzhou Med Univ, Guangzhou Inst Resp Hlth, Dept Clin Res, State Key Lab Resp Dis,Affiliated Hosp 1, Guangzhou, Peoples R China [10]Cent South Univ, Xiangya Hosp, Dept Resp & Crit Care Med, Changsha, Peoples R China [11]John Hunter Hosp, Speech Pathol, Newcastle, NSW, Australia [12]Univ Ulsan, Asan Med Ctr, Dept Allergy & Clin Immunol, Airway Sensat & Cough Res Lab,Coll Med, Seoul, South Korea [13]Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland [14]Royal Brompton & Harefield NHS Trust, Dept Resp Med, London, England [15]Imperial Coll London, Natl Heart & Lung Inst, Expt Studies Unit, London, England [16]Sichuan Univ, Frontiers Sci Ctr Dis Related Mol Network, Resp Microbiome Lab, Chengdu, Peoples R China
出处:
ISSN:

摘要:
Background: Cough is often the most prominent and intractable symptom reported by patients with asthma, but few studies have explored the characteristics of patients with asthma and with chronic cough (CC) in a real-world setting. Methods: In a prospective cohort study, patients ages 18 years with stable asthma were consecutively recruited at the West China Hospital, Sichuan University. The patients were classified as having asthma with CC (the CC group) or asthma with non-CC (the non-CC group) after 3 months of optimized asthma therapy according to standard guidelines. Multidimensional assessment was performed at baseline, followed by a 12-month follow-up to assess asthma exacerbations. Results: Of 323 patients with asthma, 127 patients were assigned to the CC group and 196 patients were assigned to the non-CC group. The participants with CC were older and had more airflow obstruction; worse asthma control and quality of life; increased airway inflammation; upper respiratory tract infection as a trigger; and more comorbidities, such as psychological dysfunction, rhinitis, chronic obstructive pulmonary disease, and bronchiectasis. They reported greater work productivity loss and daily activity impairment, and increased moderate-to-severe exacerbations. Conclusion: The participants with asthma and with CC had a significant disease burden, with increased exacerbations, health-care utilization, and impaired work productivity and daily activity. These observations indicated potential clinical implications in patients with asthma and with CC, and call for more attention to this aspect of asthma.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 3 区 医学
小类 | 3 区 过敏
最新[2025]版:
大类 | 3 区 医学
小类 | 4 区 过敏
JCR分区:
出版当年[2020]版:
Q3 ALLERGY
最新[2023]版:
Q2 ALLERGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Sichuan Univ, West China Hosp, Clin Res Ctr Resp Dis, Dept Resp & Crit Care Med, Chengdu 610041, Sichuan, Peoples R China [2]Sichuan Univ, Frontiers Sci Ctr Dis Related Mol Network, Lab Pulm Immunol & Inflammat, Chengdu, Peoples R China [3]Sichuan Univ, West China Hosp, Dept Integrated Tradit Chinese & Western Med, Pneumol Grp, Chengdu, Peoples R China
通讯作者:
通讯机构: [1]Sichuan Univ, West China Hosp, Clin Res Ctr Resp Dis, Dept Resp & Crit Care Med, Chengdu 610041, Sichuan, Peoples R China [2]Sichuan Univ, Frontiers Sci Ctr Dis Related Mol Network, Lab Pulm Immunol & Inflammat, Chengdu, Peoples R China [16]Sichuan Univ, Frontiers Sci Ctr Dis Related Mol Network, Resp Microbiome Lab, Chengdu, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:2 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)